392 related articles for article (PubMed ID: 25609972)
1. Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists.
Fausel R; Afzali A
Ther Clin Risk Manag; 2015; 11():63-73. PubMed ID: 25609972
[TBL] [Abstract][Full Text] [Related]
2. Golimumab for moderately to severely active ulcerative colitis.
Kedia S; Ahuja V; Makharia GK
Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886
[TBL] [Abstract][Full Text] [Related]
3. Golimumab for the treatment of ulcerative colitis.
Flamant M; Paul S; Roblin X
Expert Opin Biol Ther; 2017 Jul; 17(7):879-886. PubMed ID: 28472597
[TBL] [Abstract][Full Text] [Related]
4. Treatment of ulcerative colitis.
Blonski W; Buchner AM; Lichtenstein GR
Curr Opin Gastroenterol; 2014 Jan; 30(1):84-96. PubMed ID: 24285003
[TBL] [Abstract][Full Text] [Related]
5. Promising biological therapies for ulcerative colitis: A review of the literature.
Akiho H; Yokoyama A; Abe S; Nakazono Y; Murakami M; Otsuka Y; Fukawa K; Esaki M; Niina Y; Ogino H
World J Gastrointest Pathophysiol; 2015 Nov; 6(4):219-27. PubMed ID: 26600980
[TBL] [Abstract][Full Text] [Related]
6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
Lawson MM; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
[TBL] [Abstract][Full Text] [Related]
8. [Golimumab Therapy in Ulcerative Colitis].
Moon W
Korean J Gastroenterol; 2016 Feb; 67(2):64-73. PubMed ID: 26907481
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging biologics for ulcerative colitis.
Park SC; Jeen YT
Gut Liver; 2015 Jan; 9(1):18-27. PubMed ID: 25547087
[TBL] [Abstract][Full Text] [Related]
10. Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target.
Sparrow MP
Expert Opin Biol Ther; 2017 May; 17(5):613-621. PubMed ID: 28316250
[TBL] [Abstract][Full Text] [Related]
11. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
12. How important is onset of action in ulcerative colitis therapy?
Masson S; Nylander D; Mansfield JC
Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.
Vande Casteele N; Khanna R
Pharm Res; 2017 Aug; 34(8):1556-1563. PubMed ID: 28374338
[TBL] [Abstract][Full Text] [Related]
14. Golimumab: clinical update on its use for ulcerative colitis.
Gilardi D; Fiorino G; Allocca M; Bravatà I; Danese S
Drugs Today (Barc); 2015 Mar; 51(3):171-84. PubMed ID: 25876561
[TBL] [Abstract][Full Text] [Related]
15. Biologic Therapies in Ulcerative Colitis: Primi Inter Pares?
Allocca M; Fiorino G; Gilardi D; Preatoni P; Papa A; Peyrin-Biroulet L; Danese S
Curr Drug Targets; 2018; 19(7):748-756. PubMed ID: 27231106
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy versus surgery in moderate-to-severe ulcerative colitis.
Fiorino G; Danese S; Giacobazzi G; Spinelli A
Dig Liver Dis; 2021 Apr; 53(4):403-408. PubMed ID: 33051163
[TBL] [Abstract][Full Text] [Related]
17. Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis.
Pugliese D; Felice C; Landi R; Papa A; Guidi L; Armuzzi A
Drug Healthc Patient Saf; 2016; 8():1-7. PubMed ID: 26893582
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
[TBL] [Abstract][Full Text] [Related]
19. The biologics of ulcerative colitis.
Macaluso FS; Renna S; Orlando A; Cottone M
Expert Opin Biol Ther; 2017 Feb; 17(2):175-184. PubMed ID: 27960557
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
